Home Serum Immunoproteomics Combined With Pathological Reassessment of Surgical Specimens Identifies TCP-1zeta Autoantibody as a Potential Biomarker in Thyroid Neoplasia.
|

Serum Immunoproteomics Combined With Pathological Reassessment of Surgical Specimens Identifies TCP-1zeta Autoantibody as a Potential Biomarker in Thyroid Neoplasia.

Print
Share

Also of interest

New mechanism of cortisone action deciphered

Sjögren-Tag 2024 am 6. April bei der Deutschen Rheuma-Liga Berlin

Sign up for the
DRFZ NewsFlash